(Q33693343)

English

A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

peripheral neuropathy

1 reference

based on heuristic

inferred from title

Chemotherapy-induced peripheral neuropathy

1 reference

based on heuristic

inferred from title

author name string

Jennifer S Gewandter

1

1 reference

Europe PubMed Central

28 July 2017

Supriya G Mohile

2

1 reference

Europe PubMed Central

28 July 2017

Charles E Heckler

3

1 reference

Europe PubMed Central

28 July 2017

Julie L Ryan

4

1 reference

Europe PubMed Central

28 July 2017

Jeffrey J Kirshner

5

1 reference

Europe PubMed Central

28 July 2017

Patrick J Flynn

6

1 reference

Europe PubMed Central

28 July 2017

Judith O Hopkins

7

1 reference

Europe PubMed Central

28 July 2017

Gary R Morrow

8

1 reference

Europe PubMed Central

28 July 2017

publication date

16 February 2014

1 reference

Europe PubMed Central

28 July 2017

Supportive Care in Cancer

1 reference

Europe PubMed Central

28 July 2017

22

1 reference

Europe PubMed Central

28 July 2017

7

1 reference

Europe PubMed Central

28 July 2017

1807-1814

1 reference

Europe PubMed Central

28 July 2017

https://scigraph.springernature.com/pub.10.1007/s00520-014-2158-7

0 references

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Topical preparations for pain relief: efficacy and patient adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Chemotherapy-induced neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Peripheral nerve damage associated with administration of taxanes in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Clinical approach to patients with neuropathic pain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Inhibition of neuronal Na+ channels by antidepressant drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Burden of chemotherapy-induced neuropathy--a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

The interaction of ketamine with the opiate receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

30 October 2018

Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

30 October 2018

A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

30 October 2018

Weekly cisplatin +- glutathione in relapsed ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Chemotherapy-induced peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24531792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-014-2158-7

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33693343&oldid=1982290782"